Welby Inc.

Tokyo Stock Exchange 4438.T

Welby Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -62.00 K

Welby Inc. Net Cash Used Provided By Financing Activities is USD -62.00 K for the year ending December 31, 2023, a 6.94% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Welby Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -66.63 K, a -7.43% change year over year.
Welby Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -62.02 K, a -132.05% change year over year.
Welby Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 193.50 K, a -95.10% change year over year.
Welby Inc. Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD 3.95 M, a 6,162.04% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Tokyo Stock Exchange: 4438.T

Welby Inc.

CEO	Mr. Takeru Hiki
IPO Date	April 1, 2019
Location	Japan
Headquarters	Nomura Real Estate Nihonbashihoncho Bldg
Employees	53
Sector	Health Care
Industries Telehealth Hospitals & Clinics Pharmaceuticals

Description

Welby Inc. provides digital health solutions that help patients to get medical care services. The company offers services in the areas of diabetes mellitus, lifestyle related disease, mental illness, autoimmune disease, neurological disease, rare disease, oncology, and pain. It also engages in the medical data survey business; and operates Welby My Carte platform. The company was incorporated in 2011 and is based in Tokyo, Japan.

Key trends

Past 5 years